查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1137777

医疗包装市场 - 增长、趋势、COVID-19 影响和预测（2022-2027 年）

Healthcare Packaging Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

医疗包装市场预计在预测期内（2022-2027 年）将以 6.4% 的复合年增长率增长。

此外，随着高科技设备和仪器的部署以提高效率以及对可持续包装和加工操作的需求，医疗保健行业已从传统的医疗保健形式发展到目前的先进水平。上升。

主要亮点

  • 对环境问题和政府法规的认识不断提高，正在推动製药公司转向可持续的流程。此外，由于医疗器械和药品供应商的发展，医疗保健包装市场具有全球扩张空间。
  • 医疗器械包装必须为内容物提供无菌环境，并在打开包装使用之前保持无菌状态。随着医院、治疗设备和诊断中心数量的增加，医疗保健行业继续增长。由于环境问题的增加和对微生物包装的需求不断增长，预计无菌包装的销售额将增加。
  • 医疗保健公司投资于先进的机器以提高包装速度和效率。例如，数字技术、物联网和区块链使公司能够将家用电器连接到智能设备，以排除故障和报告错误、优化运营、深入了解机器数据以及记录跨供应链的数据。
  • Amcor PLC 在 2022 年 5 月表示，对可持续包装的需求包括对药品包装公司的监管压力。药品包装在立法对可持续性的关注中呈上升趋势。如果包装被认为是不可回收的，企业可能会受到拟议的扩展生产者责任 (EPR) 税和罚款的约束。某些类型的药品包装是不可回收的，可能会受到该法律的影响。
  • 此外，自 2022 年 5 月起，根据美国食品药品监督管理局 (Food & Drug Administration) 的规定，DQSA 的第二章《药品供应链安全法》(DSCSA) 会在某些处方药进入美国时对其进行识别和跟踪。为此，它概述了在包裹级别实现可互操作的电子跟踪的步骤。这将增强 FDA 保护消费者免受假冒、被盗、受污染或其他有害药品的侵害的能力。这些需求还促使公司开发可持续的包装解决方案，以改善从药品供应链中检测和清除潜在有害药物的能力，从而保护美国消费者。
  • 药品包装行业也因其产品的脆弱性而面临许多挑战。包装不当会导致开发产品发生化学变化，影响癒合和无效性能。还存在诸如供应链中断、监管问题和假冒商品等挑战。
  • 此外，COVID-19 的传播对市场产生了一定的负面影响，因为全球工厂已长期关闭，供应链已中断。瓶子、小瓶和安瓿瓶製造商在供应製药公司时面临物流挑战。诸如此类的案例正在製约市场的增长。

主要市场趋势

泡罩包装有望显着增长

  • 泡罩包装是最流行和最方便的剂型之一。医疗保健包装行业的公司为传统市场产品提供了一种经济的替代方案，使医疗保健和製药公司能够满足可持续发展目标和保质期要求。泡罩包装用于医疗器械和器械，例如导管和皮下注射器。然而，泡罩包装对于医疗器械包装的用处不如药品包装。
  • 新疾病的出现、精明客户的出现以及以公共卫生保健为重点的 OTC（非处方药）的增长正在加速泡罩包装在製药行业的增长。此外，泡罩包装越来越受欢迎，以保护药物免受潮湿。为了应对这些趋势，Burgopak 和 Ecobliss 等公司正在开发创新的儿童安全泡罩包装。
  • 市场供应商正在采取重要的先行者举措来应对材料的使用。例如，2021 年 10 月，Astellas开始在其泡罩包装中使用植物衍生的生物质衍生聚合物作为药品的初级包装。这种泡罩包装含有 50% 的生物质衍生塑料聚乙烯，由甘蔗製成。这是一个绿色包装，它坚定地坚持追求温室气体排放和吸收之间平衡的碳中和概念。
  • 此外，Amcoa 于 2021 年 4 月发布了 Custom Trail，这是第一个基于可回收聚乙烯的热成型泡罩包装。新包装预计将于 2022 年下半年上市，并符合高度专业化和受监管的药品包装的严格标准，同时为高需求的医疗保健包装类型提供更可持续的替代方案。与其他包装形式相比，碳足迹高达 70%。
  • 此外，医疗保健、营养和製药行业越来越意识到需要减少需要数年才能降解的塑料的使用，并为供应商提供与平板电脑相同的质量和存储空间。推出与无塑料泡罩包装，经久耐用。泡罩包装设计中固有的许多优点与製药行业的当前需求是一致的。因此，泡罩包装已成为行业中增长最快的包装选择之一，并将继续如此。

北美有望主导市场

  • 在北美，美国和加拿大是经济蓬勃发展、人口老龄化、医疗保健提供系统完善、国内生产总值 (GDP) 水平和医疗保险水平较高的国家。然而，由于其作为领先的初级保健地区的地位、强大的医疗保健和生命科学研究活动、医疗保健支出的高度集中以及重磅药物，美国是医疗保健包装产品的最大地理市场。
  • 根据 IQVIA Inc. 于 2021 年 5 月进行的一项研究，美国的净医疗保健支出总额将从 2020 年的 3590 亿美元增加到 2025 年的 3800 亿美元至 4000 亿美元，年復合增长率为预计为 0% 至 3%。新品牌的推出预计将继续创下历史新高，每年推出 50 至 55 种新的活性成分，到 2025 年花费约 1330 亿美元，略高于过去五年。
  • 此外，由于从加拿大以外的国家进口大量药品，美国政府已批准批发商和药剂师从加拿大进口 FDA 批准的药品的试点项目。 FDA 已经实施了一条从加拿大进口某些处方药的合法途径，以降低某些处方药对美国消费者的成本，而不会给公共健康和安全带来新的风险。我来了。这将增加对该国的进口并推动医疗保健包装市场。
  • 公司还专注于扩大业务以获取更多收入并保持市场竞争力。例如，2022 年 6 月，Guardian Medical USA 最近筹集了超过 200 万美元的私人资金，专注于骨科医疗器械市场的无菌屏障包装。有了这笔资金，公司计划加速产品开发和设施增长，以满足对使用刚性管材对各种类型和尺寸的骨科植入物和设备进行无菌包装的日益增长的需求和兴趣。
  • 同样，在 2021 年 9 月，Jones Healthcare Group 和 Good Nature Products, Inc. 合作在一个新的创新设施中扩展可持续包装解决方案。借助这种基于植物的新解决方案，Jones 计划在大多数北美家庭中简化包装设计、消除化学问题并实现易于回收的包装。这种新的定制泡罩包装的成分可在加拿大各地的独立国家连锁药店购买。

竞争格局

医疗保健包装市场适度细分。少数主要参与者目前在市场上占据主导地位，包括 Gerresheimer AG、Corning Incorporated、Nipro Corporation、West Pharmaceutical Services 和 SGD SA，并且在市场份额方面也占据主导地位。这些巨头致力于垄断市场并增加其在众多国家的客户群。这些公司使用战术合资企业来增加市场份额和盈利能力。

  • 2022 年 5 月 - Gerresheimer AG 与药物开发公司 ISR 签署了一项协议，为干粉疫苗 COVID-19 的 III 期试验大规模生产 IcoOne 鼻吸入器。作为製药、生物技术、医疗保健和化妆品领域的合作伙伴，Gelesheimer 提供最广泛的产品，包括用于药品和化妆品的包装解决方案和给药系统。
  • 2022 年 1 月 - 创新型注射给药解决方案提供商 West Pharmaceutical Services, Inc. 宣布与 Corning, Inc. 建立独家供应和技术合作伙伴关係。新的合作伙伴关係扩展了Corning的 Valor Glass 技术，为製药行业提供先进的注射包装和输送系统，有望提高患者的安全性并增加获得挽救生命的治疗的机会。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法

第 3 章执行摘要

第 4 章市场洞察

  • 市场概览
  • 评估 COVID-19 对市场的影响
  • 产业吸引力五力分析分析
    • 供应商的议价能力
    • 消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 工业价值链分析

第五章市场动态

  • 市场驱动力
    • 环境问题的便利性和重要性日益增加
    • 药品假冒的兴起导致先进的包装和标籤
  • 市场挑战
    • 与包装原材料相关的环境问题和价格竞争

第 6 章市场细分

  • 按最终用户行业
    • 药品
    • 医疗设备
  • 按产品类型
    • 瓶/容器
    • 小瓶和安瓿
    • 墨盒/注射器
    • 小袋/包
    • 吸塑包装
    • 管
    • 纸板箱
    • 封盖
    • 标籤
    • 其他产品类型
  • 按材料
    • 玻璃
    • 塑料
    • 其他材料（纸、金属）
  • 按地区列出
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 其他亚太地区
    • 拉丁美洲
      • 墨西哥
      • 巴西
      • 其他拉丁美洲地区
    • 中东和非洲
      • 南非
      • 海湾合作委员会 (GCC)
      • 其他中东

第 7 章竞争格局

  • 公司简介
    • Gerresheimer AG
    • Corning Incorporated
    • Nipro Corporation
    • SGD SA
    • Stolze-Oberglas GmbH
    • Bormioli Pharma SRL
    • Schott AG
    • Shandong Medicinal Glass Co. Ltd
    • Beatson Clark PLC
    • Arab Pharmaceutical Glass Co
    • Piramal Glass Pvt Ltd
    • Sisecam Group

第八章投资分析

第 9 章调查市场展望

简介目录
Product Code: 57354

The Healthcare Packaging Market is expected to grow at a CAGR of 6.4% during the forecast period (2022 to 2027). Moreover, the healthcare industry has grown from its traditional form of practice to its current advanced position, where high-tech equipment and instruments are deployed to improve efficiency and increase demand for sustainable packaging and processing operations.

Key Highlights

  • The rising awareness of environmental issues and government regulations are pushing pharmaceutical organizations to move toward sustainable processes. Also, developments by medical device and pharmaceutical vendors provide scope for expanding the healthcare packaging market globally.
  • The packaging of medical devices should provide a sterile environment for their contents and remain sterile until the packaging is opened for use. The healthcare industry is growing with an increasing number of hospitals, treatment devices, and diagnostic centers. Sales of aseptic packaging are expected to increase due to growing environmental concerns and rising demand for microbial packaging.
  • Healthcare companies are investing in advanced machines to increase packaging speed and efficiency. For instance, digital technology, IoT, and the blockchain allow enterprises to connect appliances to smart devices, troubleshoot and report errors, optimize operations, gain insights into machine-wide data, and record data across the supply chain.
  • According to Amcor PLC in May 2022, the need for sustainable packaging includes regulatory pressure on pharmaceutical packaging companies. Pharmaceutical packaging is increasing within the scope of sustainability-oriented legislation. If the package is considered non-recyclable, the company could be subjected to the proposed Extended Producer Responsibility (EPR) taxes and penalties. Several types of pharmaceutical packaging are not recyclable and can be affected by this law.
  • Further, as of May 2022, According to Food & Drug Administration, Title II of DQSA, the Drug Supply Chain Security Act (DSCSA), outlines steps to accomplish interoperable, electronic tracing of products at the package level to identify and trace certain prescription drugs as they are distributed in the United States. This will enhance FDA's capability to help safeguard consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. These needs will also improve the detection and removal of potentially harmful drugs from the drug supply chain to protect U.S. consumers and drive companies to develop sustainable packaging solutions.
  • The pharmaceutical packaging industry also faces many challenges due to the delicate nature of its products. Inadequate packaging can cause chemical changes in the development, affecting its healing ability and ineffective performance. Some challenges include supply chain disruptions, regulatory concerns, and counterfeit products.
  • Moreover, the spread of COVID-19 has negatively impacted the market to a certain extent due to disruptions in the supply chain due to extended factory closures globally. Logistically, it has been difficult for bottles, vials, and ampoules makers to provide to the pharma companies. Such instances restrain the growth of the market.

Key Market Trends

Blister Packs are Expected to Witness Significant Growth

  • Blister packs are one of the popular and convenient dosage formats. Companies operating in the healthcare packaging industry are economical alternatives to those offered in traditional markets where healthcare and pharmaceutical companies meet sustainability goals and shelf life requirements. Blister packs are used in medical devices and instruments such as catheters and subcutaneous syringes. However, blister packs are less useful in packaging medical devices than in pharmaceutical packaging.
  • The occurrence of new diseases focused on population health management, the emergence of informed customers, and the growth of OTC (over-the-counter) drugs have augmented the growth of blister packaging in the pharmaceutical industry. Also, blister packaging has gained popularity to protect medication from moisture. In response to these trends, companies like Burgopak and Ecobliss have developed innovative blister packaging that is child-proof.
  • Market vendors are making significant first-mover initiatives catering to material use. For instance, in October 2021, Astellas started employing plant-derived biomass-based polymers in blister packages as the primary packaging for pharmaceutical items. The blister package contains 50% biomass-based plastic polyethylene generated from sugarcane. It's a green packaging that adheres to the notion of carbon neutrality, which seeks to balance greenhouse gas emissions and absorption.
  • Further, in April 2021, Amcor announced custom trails for the first recyclable polyethylene-based thermoform blister packaging. The new packaging is expected to launch in the market in the second half of 2022, which is designed to meet the strict standards of highly specialized and regulated pharmaceutical packaging while also providing a more sustainable alternative to the in-demand healthcare packaging type. Compared to other packaging options, the packaging has a carbon footprint of up to 70%.
  • Moreover, as the healthcare, nutritional, and pharmaceutical industries are becoming mindful of the need to reduce the use of plastics that may take many years to degrade, there is an increased pressure on vendors to bring out plastic-free blister packs that may provide the same quality and maintain the shelf life of the pills. Many of the benefits inherent in the blister pack design align with the pharmaceutical industry's current demands. As a result, blister packs have been and may continue to be one of the fastest-growing packaging options in the industry.

North America is Expected to Dominate the Market

  • In North America, the United States and Canada are countries with booming economies, aging population segments, well-developed health care delivery systems, gross domestic product (GDP) levels, and health insurance. However, the United States is one of the largest geographic markets for healthcare packaged products due to its advanced primary care community, extensive healthcare and life sciences research activities, high healthcare cost concentration, and large pharmaceuticals.
  • According to a survey conducted by IQVIA Inc. in May 2021, total net health care costs are expected to rise from USD 359 billion in 2020 to USD 380 billion to USD 400 billion in 2025, with annual compound interest growth of 0% to 3% in the United States. New brand launches are anticipated to continue at record levels, with 50-55 new active ingredients expected to be launched each year, about USD 133 billion to be spent by 2025, slightly higher than in the last five years.
  • Also, as the United States faces high drug imports from countries other than Canada, the U.S. government has approved a pilot project for wholesalers and pharmacists to import FDA-approved drug versions from Canada. The FDA implements a legal route to import certain prescription drugs from Canada to reduce the cost of certain prescription drugs to U.S. consumers without introducing additional risks to public health and safety. This leverages the healthcare packaging market with more imports into the country.
  • Companies are also focused on the expansions of their business to gain more revenue in the market and sustain the competition. For instance, in June 2022, focusing on sterile barrier packages for the orthopedic medical device market, Guardian Medical USA recently raised more than USD 2.0 million in private funding. With this funding, the company will accelerate product development and facility growth to meet the growing demand and interest in using rigid tubes for sterile packaging orthopedic implants and devices of all types and sizes.
  • Similarly, in September 2021, Jones Healthcare Group and Good Natured Products Inc partnered to expand sustainable packaging solutions at a new and innovative facility. With this new plant-based solution, Jones will streamline packaging design, eliminate concerns about chemicals, and make packaging easier to recycle in most homes in North America. Materials for this new custom blister pack are available from independent national chain pharmacies throughout Canada.

Competitive Landscape

The healthcare packaging market is moderately fragmented. Currently, a small number of significant players dominate the market in terms of market share, including Gerresheimer AG, Corning Incorporated, Nipro Corporation, West Pharmaceutical Services, SGD SA, and others. These major players dominate the market and concentrate on growing their clientele across numerous nations. These businesses use tactical joint ventures to raise their market shares and profitability.

  • May 2022 - Gerresheimer AG has signed a contract with ISR, a drug development company, for the large-scale production of the nasal inhaler IcoOne for Phase III trials of the dry powder COVID-19 vaccine. Gerresheimer is a partner in pharmaceuticals, biotechnology, healthcare, and cosmetics, offering a very wide range of products for pharmaceutical and cosmetic packaging solutions and drug delivery systems.
  • January 2022 - West Pharmaceutical Services, Inc., a provider of innovative injectable drug delivery solutions, has announced an exclusive supply and technical agreement with Corning Incorporated. The new collaboration extends Corning's Valor Glass technology, which enables advanced injectable packaging and delivery systems for the pharmaceutical industry to improve patient safety and increase access to life-saving therapies.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHT

  • 4.1 Market Overview
  • 4.2 Assessment of the Impact of COVID-19 on the Market
  • 4.3 Industry Attractiveness Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Industry Value Chain Analysis

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increased Emphasis on Convenience and Environmental Issues
    • 5.1.2 Rise In Medicine Counterfeiting Leading to Advanced Packaging and Labeling
  • 5.2 Market Challenges
    • 5.2.1 Environmental Concerns Related to Raw Materials for Packaging and Price Competition

6 MARKET SEGMENTATION

  • 6.1 By End-User Vertical
    • 6.1.1 Pharmaceutical
    • 6.1.2 Medical Devices
  • 6.2 By Product Type
    • 6.2.1 Bottles and Containers
    • 6.2.2 Vials and Ampoules
    • 6.2.3 Cartridges and Syringes
    • 6.2.4 Pouches and Bags
    • 6.2.5 Blister Packs
    • 6.2.6 Tubes
    • 6.2.7 Paper Board Boxes
    • 6.2.8 Caps and Closures
    • 6.2.9 Labels
    • 6.2.10 Other Product Types
  • 6.3 By Material
    • 6.3.1 Glass
    • 6.3.2 Plastic
    • 6.3.3 Other Materials (Paper and Metal)
  • 6.4 By Geography
    • 6.4.1 North America
      • 6.4.1.1 United States
      • 6.4.1.2 Canada
    • 6.4.2 Europe
      • 6.4.2.1 United Kingdom
      • 6.4.2.2 Germany
      • 6.4.2.3 Spain
      • 6.4.2.4 Italy
      • 6.4.2.5 Rest of Europe
    • 6.4.3 Asia Pacific
      • 6.4.3.1 China
      • 6.4.3.2 Japan
      • 6.4.3.3 India
      • 6.4.3.4 Australia
      • 6.4.3.5 Rest of Asia Pacific
    • 6.4.4 Latin America
      • 6.4.4.1 Mexico
      • 6.4.4.2 Brazil
      • 6.4.4.3 Rest of Latin America
    • 6.4.5 Middle East and Africa
      • 6.4.5.1 South Africa
      • 6.4.5.2 Gulf Cooperation Council (GCC)
      • 6.4.5.3 Rest of Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Gerresheimer AG
    • 7.1.2 Corning Incorporated
    • 7.1.3 Nipro Corporation
    • 7.1.4 SGD SA
    • 7.1.5 Stolze-Oberglas GmbH
    • 7.1.6 Bormioli Pharma SRL
    • 7.1.7 Schott AG
    • 7.1.8 Shandong Medicinal Glass Co. Ltd
    • 7.1.9 Beatson Clark PLC
    • 7.1.10 Arab Pharmaceutical Glass Co
    • 7.1.11 Piramal Glass Pvt Ltd
    • 7.1.12 Sisecam Group

8 INVESTMENT ANALYSIS

9 OUTLOOK OF THE MARKET STUDIED